SCHEMBL2679795

SCHEMBL2679795

Cc1cccc(C=NNC(=O)c2ccccc2C(N)=O)c1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 4/20 0.64
▸ HPGD P15428 3/20 0.64
▸ ALDH1A1 P00352 3/20 0.64
▸ KDM4E B2RXH2 2/20 0.64
▸ SMN1; SMN2 Q16637 2/20 0.61
▸ GAA P10253 4/20 0.61
▸ MGAM O43451 1/20 0.61
▸ SI P14410 1/20 0.61
▸ MGAM2 Q2M2H8 1/20 0.61
▸ NPC1 O15118 2/20 0.57
▸ NPSR1 Q6W5P4 3/20 0.56
▸ GUSB P08236 1/20 0.54
▸ CYP1A2 P05177 1/20 0.53
▸ CYP3A4 P08684 1/20 0.53
▸ CYP2D6 P10635 1/20 0.53
▸ CYP2C9 P11712 1/20 0.53
▸ CYP2C19 P33261 1/20 0.53
▸ MAPT P10636 4/20 0.52
▸ HTT P42858 3/20 0.52
▸ MEN1 O00255 2/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2679797 0.88 RAB9A (0.60) RAB9AHPGDALDH1A1KDM4ESMN1; SMN2
SCHEMBL2679525 0.86 RAB9A (0.68) RAB9AHPGDALDH1A1KDM4ESMN1; SMN2
SCHEMBL2679443 0.86 RAB9A (0.55) RAB9AHPGDALDH1A1KDM4ESMN1; SMN2
SCHEMBL2680212 0.84 CYP1A2 (0.56) RAB9AHPGDALDH1A1KDM4ESMN1; SMN2
SCHEMBL2679591 0.84 MAOB (0.63) RAB9AHPGDALDH1A1KDM4ESMN1; SMN2
SCHEMBL31622507 0.82 RAB9A (0.78) RAB9AHPGDALDH1A1KDM4ESMN1; SMN2
SCHEMBL27178008 0.82 RAB9A (0.78) RAB9AHPGDALDH1A1KDM4ESMN1; SMN2
SCHEMBL30170995 0.82 RAB9A (0.78) RAB9AHPGDALDH1A1KDM4ESMN1; SMN2
SCHEMBL27178003 0.82 RAB9A (0.78) RAB9AHPGDALDH1A1KDM4ESMN1; SMN2
SCHEMBL12868832 0.81 DNM1 (0.71) RAB9AALDH1A1SMN1; SMN2GAAMGAM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120115851-A1 COMPOUND INHIBITING IN VIVO PHOSPHORUS TRANSPORT AND MEDICINE CONTAINING THE SAME KYOWA HAKKO KIRIN CO., LTD. (JP) 2012-05-10 — — US disclosed
US-20060217426-A1 Compound inhibiting in vivo phosphorous transport and medicine containing the same KIRIN BEER KABUSHIKI KAISHA (JP) 2006-09-28 — — US disclosed
EP-1614676-A1 COMPOUND INHIBITING IN VIVO PHOSPHORUS TRANSPORT AND MEDICINE CONTAINING THE SAME KIRIN BEER KABUSHIKI KAISHA (JP) 2006-01-11 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060217426-A1 Compound inhibiting in vivo phosphorous transport and medicine containing the same SLC10A6, SLC7A1, SLC10A1 RAB9A 883/4885HPGD 2509/4885ALDH1A1 3022/4885
US-20120115851-A1 COMPOUND INHIBITING IN VIVO PHOSPHORUS TRANSPORT AND MEDICINE CONTAINING THE SAME SLC34A1, SLC34A2, SLC20A2 RAB9A 1362/4885HPGD 2407/4885ALDH1A1 2872/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback